Pierluigi Marzuillo1, Stefano Guarino, Egidio Barbi. 1. Department of Women and Children and General and Specialized Surgery, Seconda Università degli Studi di Napoli, Via L. De Crecchio 2, 80138, Naples, Italy, pierluigi.marzuillo@gmail.com.
Abstract
UNLABELLED: Paracetamol (acetaminophen) is one of the most popular and widely used drugs for the treatment of pain and fever in children. This drug has multiple mechanisms of action, but its pharmacodynamic is still not well known. The central nervous system is the main site of action and it mirrors the paracetamol effect compartment. The recommended dosages and routes of administration should be different whether paracetamol is used for the treatment of pain or fever. For example, the rectal route, while being efficacious for the treatment of fever, should be avoided in pain management. Paracetamol is a safe drug, but some clinical conditions and concomitant drugs, which are frequent in clinical practice, may increase the risk of paracetamol toxicity. Therefore, it is important to optimize its administration to avoid overdoses and maximize its effect. The principal mediator of the paracetamol toxicity is the N-acetyl-p-benzo-quinone imine (NAPQI), a toxic product of the paracetamol metabolism, which could bind cysteine groups on proteins forming paracetamol-protein adduct in the liver. CONCLUSION: Although frequently prescribed, the concept of "effect compartment concentration" and the possible co-factors that could cause toxicity at recommended doses are not familiar to all pediatricians and general practitioners. We reviewed the literature concerning paracetamol mechanisms of action, we highlighted some relevant pharmacodynamic concepts for clinical practice, and we summarized the possible risk factors for toxicity at therapeutic dosages.
UNLABELLED: Paracetamol (acetaminophen) is one of the most popular and widely used drugs for the treatment of pain and fever in children. This drug has multiple mechanisms of action, but its pharmacodynamic is still not well known. The central nervous system is the main site of action and it mirrors the paracetamol effect compartment. The recommended dosages and routes of administration should be different whether paracetamol is used for the treatment of pain or fever. For example, the rectal route, while being efficacious for the treatment of fever, should be avoided in pain management. Paracetamol is a safe drug, but some clinical conditions and concomitant drugs, which are frequent in clinical practice, may increase the risk of paracetamoltoxicity. Therefore, it is important to optimize its administration to avoid overdoses and maximize its effect. The principal mediator of the paracetamoltoxicity is the N-acetyl-p-benzo-quinone imine (NAPQI), a toxic product of the paracetamol metabolism, which could bind cysteine groups on proteins forming paracetamol-protein adduct in the liver. CONCLUSION: Although frequently prescribed, the concept of "effect compartment concentration" and the possible co-factors that could cause toxicity at recommended doses are not familiar to all pediatricians and general practitioners. We reviewed the literature concerning paracetamol mechanisms of action, we highlighted some relevant pharmacodynamic concepts for clinical practice, and we summarized the possible risk factors for toxicity at therapeutic dosages.
Authors: B Bannwarth; P Netter; F Lapicque; P Gillet; P Péré; E Boccard; R J Royer; A Gaucher Journal: Br J Clin Pharmacol Date: 1992-07 Impact factor: 4.335
Authors: Hans Gühring; May Hamza; Marina Sergejeva; Mehmet Ates; Carolin E Kotalla; Catherine Ledent; Kay Brune Journal: Eur J Pharmacol Date: 2002-11-15 Impact factor: 4.432
Authors: Brian J Anderson; Gerard Pons; Elisabeth Autret-Leca; Karel Allegaert; Eric Boccard Journal: Paediatr Anaesth Date: 2005-04 Impact factor: 2.556
Authors: R W Sauerwein; J A Mulder; L Mulder; B Lowe; N Peshu; P N Demacker; J W van der Meer; K Marsh Journal: Am J Clin Nutr Date: 1997-05 Impact factor: 7.045
Authors: S Di Mario; V Basevi; R D'Amico; C Gagliotti; M Gangemi; F Marchetti; M L Moro; G Tamburlini Journal: Eur J Clin Microbiol Infect Dis Date: 2016-05-14 Impact factor: 3.267
Authors: Gregorio P Milani; Franca Benini; Laura Dell'Era; Davide Silvagni; Alberto F Podestà; Rossella Letizia Mancusi; Emilio F Fossali Journal: Eur J Pediatr Date: 2017-06-10 Impact factor: 3.183
Authors: Ingrid Rabach; Francesca Peri; Marta Minute; Emanuela Aru; Marianna Lucafò; Alberto Di Mascio; Giorgio Cozzi; Egidio Barbi Journal: World J Pediatr Date: 2019-05-16 Impact factor: 2.764
Authors: Alies Sjoukes; Roderick P Venekamp; Alma C van de Pol; Alastair D Hay; Paul Little; Anne Gm Schilder; Roger Amj Damoiseaux Journal: Cochrane Database Syst Rev Date: 2016-12-15
Authors: Genny Raffaeli; Annalisa Orenti; Monia Gambino; Walter Peves Rios; Samantha Bosis; Sonia Bianchini; Claudia Tagliabue; Susanna Esposito Journal: Int J Environ Res Public Health Date: 2016-05-13 Impact factor: 3.390